BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World J Hepatol 2019; 11(1): 1-18 [PMID: 30705715 DOI: 10.4254/wjh.v11.i1.1]
URL: https://www.wjgnet.com/1007-9327/full/v11/i1/1.htm
Number Citing Articles
1
Hala S. El-Rebey, Asmaa G. Abdou, Mervat M. Sultan, Shymaa H. Ibrahim, Nanis S. Holah. The Profile and Role of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: An Immunohistochemical StudyApplied Immunohistochemistry & Molecular Morphology 2021; 29(3): 188 doi: 10.1097/PAI.0000000000000865
2
L.E. Cisneros-Garza, M.S. González-Huezo, C. Moctezuma-Velázquez, L. Ladrón de Guevara-Cetina, M. Vilatobá, I. García-Juárez, R. Alvarado-Reyes, G.A. Álvarez-Treviño, S. Allende-Pérez, L. Bornstein-Quevedo, G. Calderillo-Ruiz, M.A. Carrillo-Martínez, M. Castillo-Barradas, E. Cerda-Reyes, J.A. Félix-Leyva, J.A. Gabutti-Thomas, J. Guerrero-Ixtlahuac, F. Higuera-de-la-Tijera, D. Huitzil-Meléndez, E. Kimura-Hayama, P.A. López-Hernández, R. Malé-Velázquez, N. Méndez-Sánchez, M.A. Morales-Ruiz, E. Ruíz-García, J.F. Sánchez-Ávila, L. Torrecillas-Torres. The second Mexican consensus on hepatocellular carcinoma. Part I: Epidemiology and diagnosisRevista de Gastroenterología de México (English Edition) 2022; 87(2): 216 doi: 10.1016/j.rgmxen.2021.10.009
3
Joanne McDonagh, Sara Bardell, Neil Rajoriya, Isobel Hayes, Tahir Shah. Managing ascites in patients with hepatocellular carcinoma: experiences from a quaternary liver centreGastrointestinal Nursing 2024; 22(Sup1): S17 doi: 10.12968/gasn.2024.22.Sup1.S17
4
Omayma A.R. AboZaid, Mostafa A. Abdel-Maksoud, Ibrahim A. Saleh, Mohamed A. El-Tayeb, Sawsan M. EL-sonbaty, Faten E. Shoker, Maha A. Salem, Ayat M. Emad, Samson Mani, Arunagiri Kuha Deva Magendhra Rao, Mohamed A. Mamdouh, Mohamed H. Kotob, Mohammed Aufy, Ahmad S. Kodous. Targeting the NF-κB p65/Bcl-2 signaling pathway in hepatic cellular carcinoma using radiation assisted synthesis of zinc nanoparticles coated with naturally isolated gallic acidBiomedicine & Pharmacotherapy 2024; 172: 116274 doi: 10.1016/j.biopha.2024.116274
5
Daniel Jesper, Daniel Klett, Barbara Schellhaas, Lukas Pfeifer, Moritz Leppkes, Maximilian Waldner, Markus F. Neurath, Deike Strobel. Ultrasound-Based Attenuation Imaging for the Non-Invasive Quantification of Liver Fat - A Pilot Study on Feasibility and Inter-Observer VariabilityIEEE Journal of Translational Engineering in Health and Medicine 2020; 8: 1 doi: 10.1109/JTEHM.2020.3001488
6
Suzan Abdu, Nouf Juaid, Amr Amin, Mohamed Moulay, Nabil Miled. Therapeutic Effects of Crocin Alone or in Combination with Sorafenib against Hepatocellular Carcinoma: In Vivo & In Vitro InsightsAntioxidants 2022; 11(9): 1645 doi: 10.3390/antiox11091645
7
Clara T. Nicolas, Caitlin J. VanLith, Raymond D. Hickey, Zeji Du, Lori G. Hillin, Rebekah M. Guthman, William J. Cao, Benjamin Haugo, Annika Lillegard, Diya Roy, Aditya Bhagwate, Daniel O’Brien, Jean-Pierre Kocher, Robert A. Kaiser, Stephen J. Russell, Joseph B. Lillegard. In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesionsNature Communications 2022; 13(1) doi: 10.1038/s41467-022-32576-7
8
Mario Capasso, Valentina Cossiga, Maria Guarino, Luisa Ranieri, Filomena Morisco. The Role of Hepatitis Viruses as Drivers of HepatocancerogenesisCancers 2024; 16(8): 1505 doi: 10.3390/cancers16081505
9
Yi Dong, Wen-Ping Wang, Won Jae Lee, Maria Franca Meloni, Dirk-Andre Clevert, Maria Cristina Chammas, Andrea Tannapfel, Antonella Forgione, Fabio Piscaglia, Christoph Frank Dietrich. Hepatocellular carcinoma in the non-cirrhotic liverClinical Hemorheology and Microcirculation 2022; 80(4): 423 doi: 10.3233/CH-211309
10
Yilin Pang, Yuanshan Lin, Xueqing Wang, Jing Wang, Qian Liu, Nan Ding, Lin Huang, Qiyu Xiang, Jun Fang, Guoqiang Tan, Jianxin Lyu, Zheng Wang. Inhibition of abnormally activated HIF-1α-GLUT1/3-glycolysis pathway enhances the sensitivity of hepatocellular carcinoma to 5-caffeoylquinic acid and its derivativesEuropean Journal of Pharmacology 2022; 920: 174844 doi: 10.1016/j.ejphar.2022.174844
11
K. P. Divya, Parneet Hari, Navjot Kanwar, Navita Aggarwal, Preeti Singh Dhoat, Lu Liu, Abhinav Kanwal, Shailendra Pratap Singh, Jiong Yu. The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and TherapeuticsAdvanced Gut & Microbiome Research 2023; 2023: 1 doi: 10.1155/2023/5431615
12
Yakup Ülger, Anıl Delik. AN UNUSUAL CASE OF RECURRENT GASTROINTESTINAL BLEEDING AND ACUTE RENAL FAILURE-RELATED HEPATOCELLULAR CARCINOMA WITH GASTRIC OUTLET OBSTRUCTIONGastroenterology Nursing 2022; 45(5): 370 doi: 10.1097/SGA.0000000000000694
13
Ellery Altshuler, Raymond Richhart, Mahmoud Aryan, William King, Kelsey Pan, Akash Mathavan, Akshay Mathavan, Diana Rodriguez, Bishal Paudel, Nathan Northern, Brian Ramnaraign, Ilyas Sahin, Jesus C Fabregas. Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective ReviewJournal of Hepatocellular Carcinoma 2022; : 1299 doi: 10.2147/JHC.S384438
14
Alessia Virzì, Victor Gonzalez-Motos, Simona Tripon, Thomas F. Baumert, Joachim Lupberger. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker DevelopmentJournal of Clinical Medicine 2021; 10(5): 977 doi: 10.3390/jcm10050977
15
Hepatic Stress Response in HCV Infection Promotes STAT3-Mediated Inhibition of HNF4A-miR-122 Feedback Loop in Liver Fibrosis and Cancer ProgressionCancers 2019; 11(10): 1407 doi: 10.3390/cancers11101407
16
Jack Leslie, Daniel Geh, Ahmed M. Elsharkawy, Derek A. Mann, Michele Vacca. Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactionsJournal of Hepatology 2022; 77(1): 219 doi: 10.1016/j.jhep.2022.01.029
17
Markus Casper, Maximilian Linxweiler, Johannes Linxweiler, Richard Zimmermann, Matthias Glanemann, Frank Lammert, Susanne N. Weber. <b><i>SEC62</i></b> and <b><i>SEC63</i></b> Expression in Hepatocellular Carcinoma and Tumor-Surrounding Liver TissueVisceral Medicine 2021; 37(2): 110 doi: 10.1159/000513293
18
Khaled Mahmoud, Shady Swidan, Mohamed El-Nabarawi, Mahmoud Teaima. Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advancesJournal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01309-9
19
Hongxin Cai, Xiaoyue Du, Yufeng Deng, Dejian Cao, Lele Wang, Zhiguo Wu, Xianchao Zhang, Jinbiao Xu, Baogang Xie. Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing ratsBioanalysis 2024; : 1 doi: 10.4155/bio-2023-0215
20
Gianvito Candita, Sara Rossi, Karolina Cwiklinska, Salvatore Claudio Fanni, Dania Cioni, Riccardo Lencioni, Emanuele Neri. Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art ReviewDiagnostics 2023; 13(4): 625 doi: 10.3390/diagnostics13040625
21
Juey-Ming Shih. Tumor Lysis Syndrome Following Thoracotomy Under Cardiopulmonary Bypass in a Case of Hepatocellular Carcinoma With Right Atrial and Inferior Vena Cava Tumor ThrombusCureus 2021;  doi: 10.7759/cureus.20311
22
Dafeng Xu, Yu Wang, Jincai Wu, Yuliang Zhang, Zhehao Liu, Yonghai Chen, Jinfang Zheng. Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular CarcinomaFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.686664
23
Mahnaz Mohammadi, Adeleh Attar, Maryam Mohammadbeigi, Amir Peymani, Shahin Bolori, Fatemeh Fardsanei. The possible role of Helicobacter pylori in liver diseasesArchives of Microbiology 2023; 205(8) doi: 10.1007/s00203-023-03602-z
24
Mauro Cataldi, Federica Manco, Giovanni Tarantino. Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate StoryInternational Journal of Molecular Sciences 2021; 22(23): 12947 doi: 10.3390/ijms222312947
25
Mélanie Simoes Eugénio, Muhammad Farooq, Sarah Dion, Christelle Devisme, Céline Raguenes-Nicol, Claire Piquet-Pellorce, Michel Samson, Marie-Thérèse Dimanche-Boitrel, Jacques Le Seyec. Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune ResponseCancers 2020; 12(6): 1491 doi: 10.3390/cancers12061491
26
Yi Dong, Sheng Chen, Kathleen Möller, Yi-Jie Qiu, Xiu-Yun Lu, Qi Zhang, Christoph F. Dietrich, Wen-Ping Wang. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic LiverUltrasound in Medicine & Biology 2023; 49(8): 1780 doi: 10.1016/j.ultrasmedbio.2023.03.026
27
Dobrochna Dolicka, Cyril Sobolewski, Marta Correia de Sousa, Monika Gjorgjieva, Michelangelo Foti. mRNA Post-Transcriptional Regulation by AU-Rich Element-Binding Proteins in Liver Inflammation and CancerInternational Journal of Molecular Sciences 2020; 21(18): 6648 doi: 10.3390/ijms21186648
28
Amreen Dinani, Norman Sussman, Mazen Noureddin, Michael Fuchs, George Therapondos, Nigel Girgrah, Viviana Figueroa Diaz, Parvez Mantry, Mary Rinella, Amon Asgharpour, Douglas Dieterich. An algorithm for the management of non-alcoholic fatty liver disease in primary careGastroenterology & Hepatology: Open Access 2021; 12(4): 114 doi: 10.15406/ghoa.2021.12.00469
29
Maryam Bilal Haider, Ali Al Sbihi, Ahmed Jamal Chaudhary, Syed M Haider, Ahmed Iqbal Edhi. Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based studyWorld Journal of Hepatology 2022; 14(9): 1804-1816 doi: 10.4254/wjh.v14.i9.1804
30
Qiaoling Wang, Binxia Chang, Xiaoyan Li, Zhengsheng Zou. Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease PathogenesisJournal of Clinical and Translational Hepatology 2021; 0(000): 1 doi: 10.14218/JCTH.2020.00104
31
Hiroko Naganuma, Hideaki Ishida. Hepatocellular Carcinoma in Non-Fibrotic Liver: A Narrative ReviewDiagnostics 2023; 13(22): 3426 doi: 10.3390/diagnostics13223426
32
Raja Chhabra, Aditya Vidushi, Sajjan Rajpurohit, Jasbir Singh, Md Ali Osama. Spontaneous Tumor Lysis Syndrome in a Case of Hepatocellular Carcinoma with Sarcomatoid DifferentiationIndian Journal of Surgical Oncology 2024; 15(2): 370 doi: 10.1007/s13193-024-01895-0
33
Mattias Lissing, Bruce Wang, Staffan Wahlin. Liver transplantation and primary liver cancer in porphyriaLiver International 2024;  doi: 10.1111/liv.15894
34
Hiroki Bessho, Satoshi Tanaka, Akio Ishihara, Shinya Kato, Reishi Toshiyama, Naoki Hama, Kiyoshi Mori, Masayuki Mano, Atsushi Miyamoto, Hisashi Ishida, Motohiro Hirao, Eiji Mita. Hepatocellular carcinoma in an adult patient with congenital absence of the portal vein type II: A case reportJGH Open 2020; 4(4): 766 doi: 10.1002/jgh3.12312
35
Benedetta Maria Motta, Mario Masarone, Pietro Torre, Marcello Persico. From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and PreventionCancers 2023; 15(22): 5458 doi: 10.3390/cancers15225458
36
Maria Cristina Cuartas-Mesa, Maria E Romero Noboa, Yasmine Choroomi, Badri Aryal, Akash Venkataramanan, Rafaella Ferreira de Araujo Litvin. A Chronic Cough and Something More: An Unusual Presentation of Hepatocellular CarcinomaCureus 2023;  doi: 10.7759/cureus.37300
37
Sehwa Kim, Yoonseok Lee, Soo Min Bang, Haein Bak, Sun Young Yim, Young Sun Lee, Yang Jae Yoo, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Soon Ho Um, Kwan Soo Byun, Jong Eun Yeon. Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV PatientsJournal of Clinical Medicine 2021; 10(9): 1840 doi: 10.3390/jcm10091840
38
Juan Pang, Ke Chen, Shen Chen, Xu Chen. Global burden of nonalcoholic steatohepatitis-related liver cancer, 1990–2019: a systematic analysis for the GBD 2019Diabetology & Metabolic Syndrome 2022; 14(1) doi: 10.1186/s13098-022-00885-y
39
Amira M. Elmoslemany, Mohamed Elzallat, Mai Hussein Abd-Elfatah, Dina Mostafa Mohammed, Eman E.Abd Elhady. Possible therapeutic effect of frankincense (Gum olibanum) and myrrh (Commiphora myrrha) resins extracts on DEN/CCL4 induced hepatocellular carcinoma in ratsPhytomedicine Plus 2024; 4(1): 100517 doi: 10.1016/j.phyplu.2023.100517
40
Dandan Huang, Dafen Xu, Wenxin Chen, Ruimei Wu, Yujuan Wen, Ailin Liu, Liqing Lin, Xinhua Lin, Xuewen Wang. Fe-MnO2 nanosheets loading dihydroartemisinin for ferroptosis and immunotherapyBiomedicine & Pharmacotherapy 2023; 161: 114431 doi: 10.1016/j.biopha.2023.114431
41
Hafiza Arooba Riaz, Dur E. Nishwa, Ameer Fatima, Braira Wahid, Akhtar Ali, Babita Kumari, Muhammad Idrees. Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosisHeliyon 2023; 9(5): e16169 doi: 10.1016/j.heliyon.2023.e16169
42
Diwakar Suresh, Akshatha N. Srinivas, Divya P. Kumar. Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver DiseaseFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.601710
43
Robert Mahn, Farsaneh Sadeghlar, Alexandra Bartels, Taotao Zhou, Tobias Weismüller, Patrick Kupczyk, Carsten Meyer, Florian C. Gaertner, Marieta Toma, Tim Vilz, Petra Knipper, Tim Glowka, Steffen Manekeller, Jörg Kalff, Christian P. Strassburg, Maria A. Gonzalez-Carmona. Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantationMedicine 2021; 100(38): e27082 doi: 10.1097/MD.0000000000027082
44
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo. Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationCancers 2023; 15(7): 1925 doi: 10.3390/cancers15071925
45
Cedric Brackenier, Lisa Kinget, Sarah Cappuyns, Chris Verslype, Benoit Beuselinck, Jeroen Dekervel. Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular CarcinomaCancers 2023; 15(2): 348 doi: 10.3390/cancers15020348
46
Vassilis G. Giannakoulis, Peter Dubovan, Eleni Papoutsi, Agapi Kataki, John Koskinas. Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future PerspectiveCancers 2021; 13(18): 4732 doi: 10.3390/cancers13184732
47
Yakup Ülger, Anil Delik. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patientsEuropean Journal of Gastroenterology & Hepatology 2022; 34(7): 769 doi: 10.1097/MEG.0000000000002341
48
Liuliu Cheng, Shichuan Hu, Jinhu Ma, Yongheng Shu, Yanwei Chen, Bin Zhang, Zhongbing Qi, Yunmeng Wang, Yan Zhang, Yuwei Zhang, Ping Cheng. Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair systemMolecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-021-00065-w
49
Antonia Reyes, Gerardo Ortiz, Luisa F. Duarte, Christian Fernández, Rosario Hernández-Armengol, Pablo A. Palacios, Yolanda Prado, Catalina A. Andrade, Linmar Rodriguez-Guilarte, Alexis M. Kalergis, Felipe Simon, Leandro J. Carreño, Claudia A. Riedel, Mónica Cáceres, Pablo A. González. Contribution of viral and bacterial infections to senescence and immunosenescenceFrontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1229098
50
Chao Ma, Longkun Fan, Jingxian Wang, Lixia Hao, Jinqiu He. Hippo/Mst1 overexpression induces mitochondrial death in head and neck squamous cell carcinoma via activating β-catenin/Drp1 pathwayCell Stress and Chaperones 2019; 24(4): 807 doi: 10.1007/s12192-019-01008-9
51
C. Nelson Hayes, Peiyi Zhang, Kazuaki Chayama. Hepatocellular Carcinoma2019; : 95 doi: 10.15586/hepatocellularcarcinoma.2019.ch5
52
Puru Rattan, Carlos D. Minacapelli, Vinod Rustgi. The Microbiome and Hepatocellular CarcinomaLiver Transplantation 2020; 26(10): 1316 doi: 10.1002/lt.25828
53
Nan Zhang, Hui Xu, A‐Hong Ren, Qian Zhang, Da‐Wei Yang, Te Ba, Zhen‐Chang Wang, Zheng‐Han Yang. Does Training in LI‐RADS Version 2018 Improve Readers' Agreement with the Expert Consensus and Inter‐reader Agreement in MRI Interpretation?Journal of Magnetic Resonance Imaging 2021; 54(6): 1922 doi: 10.1002/jmri.27688
54
Yueyue Yang, Jiafei Lin, Susu Guo, Xiangfei Xue, Yikun Wang, Shiyu Qiu, Jiangtao Cui, Lifang Ma, Xiao Zhang, Jiayi Wang. RRM2 protects against ferroptosis and is a tumor biomarker for liver cancerCancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01689-8
55
Rupie Jamwal, Venkatram Krishnan, Dinesh Singh Kushwaha, Rajat Khurana. Hepatocellular carcinoma in non-cirrhotic versus cirrhotic liver: a clinico-radiological comparative analysisAbdominal Radiology 2020; 45(8): 2378 doi: 10.1007/s00261-020-02561-z
56
Xiaobin Chi, Zhijian Chen, Yongbiao Chen, Hanyin Hong, Jianda Yu, Lizhi Lv. Upregulation of lncRNA PTOV1‐AS1 in hepatocellular carcinoma contributes to disease progression and sorafenib resistance through regulating miR‐505Journal of Biochemical and Molecular Toxicology 2023; 37(10) doi: 10.1002/jbt.23437
57
Han Deng, Wenting Shang, Kun Wang, Kunxiong Guo, Yu Liu, Jie Tian, Chihua Fang. Targeted-detection and sequential-treatment of small hepatocellular carcinoma in the complex liver environment by GPC-3-targeted nanoparticlesJournal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01378-w
58
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Razie Hadavi, Ameneh Koochaki, Mahdi Paryan. Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinomaMolecular Biology Reports 2020; 47(10): 7429 doi: 10.1007/s11033-020-05798-5
59
Benjamin Buchard, Camille Teilhet, Natali Abeywickrama Samarakoon, Sylvie Massoulier, Juliette Joubert-Zakeyh, Corinne Blouin, Christelle Reynes, Robert Sabatier, Anne-Sophie Biesse-Martin, Marie-Paule Vasson, Armando Abergel, Aicha Demidem. Two Metabolomics Phenotypes of Human Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease According to Fibrosis SeverityMetabolites 2021; 11(1): 54 doi: 10.3390/metabo11010054
60
Zongren Ding, Kongying Lin, Jun Fu, Qizhen Huang, Guoxu Fang, Yanyan Tang, Wuyi You, Zhaowang Lin, Zhan Lin, Xingxi Pan, Yongyi Zeng. An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liverWorld Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02266-7
61
Afsaneh Barzi, Kali Zhou, Songren Wang, Jennifer L. Dodge, Anthony El-Khoueiry, Veronica Wendy Setiawan. Etiology and Outcomes of Hepatocellular Carcinoma in an Ethnically Diverse Population: The Multiethnic CohortCancers 2021; 13(14): 3476 doi: 10.3390/cancers13143476
62
Jennie Engstrand, Per Stål, Stefan Gilg, Anders Jansson, Cecilia Strömberg. Hepatocellular carcinoma in cirrhotic versus non-cirrhotic liver: Treatment and survival differences in a nationwide cohortScandinavian Journal of Surgery 2024; 113(2): 120 doi: 10.1177/14574969231220179
63
Manisri Porukala, P. K. Vinod, Amy McCart Reed. Gene expression signatures of stepwise progression of Hepatocellular CarcinomaPLOS ONE 2023; 18(12): e0296454 doi: 10.1371/journal.pone.0296454
64
Stefano Mazza, Chiara Frigerio, Daniele Alfieri, Aurelio Mauro, Francesca Torello Viera, Davide Scalvini, Chiara Barteselli, Carmelo Sgarlata, Letizia Veronese, Marco Bardone, Laura Rovedatti, Simona Agazzi, Elena Strada, Lodovica Pozzi, Marcello Maestri, Valentina Ravetta, Andrea Anderloni. Prognostic Role of Basal Serum Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Suitable for Curative TreatmentMedicina 2024; 60(5): 692 doi: 10.3390/medicina60050692
65
Giovanni Vitale, Alessandro Mattiaccio, Amalia Conti, Laura Turco, Marco Seri, Fabio Piscaglia, Maria Cristina Morelli. Genetics in Familial Intrahepatic Cholestasis: Clinical Patterns and Development of Liver and Biliary Cancers: A Review of the LiteratureCancers 2022; 14(14): 3421 doi: 10.3390/cancers14143421
66
Ayoob Dinar Abdullah, Behzad Amanpour-Gharaei, Mohssen Nassiri Toosi, Sina Delazar, Hamidraza Saligheh Rad, Arvin Arian. Comparing Texture Analysis of Apparent Diffusion Coefficient MRI in Hepatocellular Adenoma and Hepatocellular CarcinomaCureus 2024;  doi: 10.7759/cureus.51443
67
Ahmed M Badheeb, Mohammed K Al Sedran, Faisal Ahmed, Ibrahim K Al Sidran, Mohammed H Al Qurayshah, Abdullah Abu Bakar, Hamoud Y Obied, Islam A Seada, Abdelaziz Aman, Mohamed Badheeb. Clinical Characteristics and Survival of Hepatocellular Carcinoma: Insights from Single-Centre Experience in Saudi ArabiaCureus 2024;  doi: 10.7759/cureus.52608
68
Qimeng Chang, Yayun Xu, Jianfa Wang, Hui Jing, Longhua Rao, Weiguo Tang, Ziping Zhang, Xubo Wu, Jianxin Shi. SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular CarcinomaComputational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/8556888
69
Philip J. Johnson, Anton Kalyuzhnyy, Ellen Boswell, Hidenori Toyoda. Progression of chronic liver disease to hepatocellular carcinoma: implications for surveillance and managementBJC Reports 2024; 2(1) doi: 10.1038/s44276-024-00050-0
70
Dina Sweed, Enas Sweed, Inas Moaz, Asmaa Mosbeh, Yahya Fayed, Sara Mohamed Abd Elhamed, Eman Sweed, Mahmoud Macshut, Shimaa Abdelsattar, Shimaa Kilany, Sara A. Saied, Reda Badr, Mahmoud S. Abdallah, Nermine Ehsan. The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in EgyptWorld Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02764-2
71
Wasitha P.D. Wass Thilakarathna, H.P. Vasantha Rupasinghe, Neale D. Ridgway. Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2021; 22(5): 2606 doi: 10.3390/ijms22052606
72
Sarah El-Nakeep. Molecular and genetic markers in hepatocellular carcinoma: <i>In silico </i>analysis to clinical validation (current limitations and future promises)World Journal of Gastrointestinal Pathophysiology 2022; 13(1): 1-14 doi: 10.4291/wjgp.v13.i1.1
73
Clara Bihain, Jean Delwaide, Paul Meunier, Laurent Gerard, Alexandre Jadoul, Olivier Detry. Successful multimodal management of a large hepatocellular carcinoma in a non-cirrhotic liver: a case reportActa Chirurgica Belgica 2024; 124(3): 229 doi: 10.1080/00015458.2023.2234724
74
Joscha Vonderlin, Triantafyllos Chavakis, Michael Sieweke, Frank Tacke. The Multifaceted Roles of Macrophages in NAFLD PathogenesisCellular and Molecular Gastroenterology and Hepatology 2023; 15(6): 1311 doi: 10.1016/j.jcmgh.2023.03.002
75
Srikanta Dash, Yucel Aydin, Kyle E Widmer, Leela Nayak. <p>Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment</p>Journal of Hepatocellular Carcinoma 2020; : 45 doi: 10.2147/JHC.S221187
76
Santhosh Anand, Loganathan Jayapal, Siddhesh Suresh Tasgaonkar Ema, Jainudeen Khalander Abdul Jameel, Prasanna Kumar Reddy. Laparoscopic right posterior sectionectomy for a large hepatocellular carcinoma close to inferior vena cavaJournal of Minimally Invasive Surgery 2023; 26(3): 162 doi: 10.7602/jmis.2023.26.3.162
77
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and ManagementEndocrine Reviews 2020; 41(1): 66 doi: 10.1210/endrev/bnz009
78
Hsin-Yeh Chen, Kwong-Ming Kee, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen, Yuan-Hung Kuo. Incorporating albumin-bilirubin grade and up-to-seven criteria to predict outcomes of patients with intermediate stage hepatocellular carcinoma after transarterial (chemo)embolizationJournal of the Formosan Medical Association 2022; 121(4): 778 doi: 10.1016/j.jfma.2021.07.003
79
Xuan-vinh Kevin Nguyen, Jason Zhang, Ken Lee Chin, Stephen Bloom, Amanda J. Nicoll. Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver?Nutrients 2022; 14(18): 3875 doi: 10.3390/nu14183875
80
Georgi Atanasov, Karoline Dino, Katrin Schierle, Corinna Dietel, Gabriela Aust, Johann Pratschke, Daniel Seehofer, Moritz Schmelzle, Hans-Michael Hau. Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomesWorld Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1635-3
81
Scott L. Friedman, Arun J. Sanyal. The future of hepatologyHepatology 2023; 78(2): 637 doi: 10.1097/HEP.0000000000000389
82
Sheng Chen, Yi-Jie Qiu, Dan Zuo, Shuai-Nan Shi, Wen-Ping Wang, Yi Dong. Imaging Features of Hepatocellular Carcinoma in the Non-Cirrhotic Liver with Sonazoid-Enhanced Contrast-Enhanced UltrasoundDiagnostics 2022; 12(10): 2272 doi: 10.3390/diagnostics12102272
83
Arun Kumar Gunasekaran, Amit Malviya, Tony Ete, Animesh Mishra, Bhupen Barman, Md Jamil, Donboklang Lynser. Hepatocellular Carcinoma with Inferior Vena Cava and Right Atrium Tumor ThrombusActa medica Lituanica 2021; 28(2): 10 doi: 10.15388/Amed.2021.28.2.10
84
Lampros Chrysavgis, Ilias Giannakodimos, Panagiota Diamantopoulou, Evangelos Cholongitas. Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing linkWorld Journal of Gastroenterology 2022; 28(3): 310-331 doi: 10.3748/wjg.v28.i3.310
85
Eloy Ruiz, Jorge Honles, Ramiro Fernández, Karla Uribe, Juan P. Cerapio, Karina Cancino, Juan Contreras-Mancilla, Sandro Casavilca-Zambrano, Francisco Berrospi, Pascal Pineau, Stéphane Bertani. A preoperative risk score based on early recurrence for estimating outcomes after resection of hepatocellular carcinoma in the non-cirrhotic liverHPB 2024; 26(5): 691 doi: 10.1016/j.hpb.2024.02.010
86
Jing Yao, Zhe Yang, Jun Yang, Zhi-Gang Wang, Zheng-Yun Zhang. Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axisAging 2021; 13(10): 13726 doi: 10.18632/aging.202960
87
Haeryoung Kim, Wei-Qiang Leow, Regina Lo, Paulo Giovanni L. Mendoza, Anthony Wing-Hung Chan. Atlas of Hepatocellular Carcinoma Pathology2022; : 3 doi: 10.1007/978-981-16-8500-2_2
88
Daniel Q. Huang, Hashem B. El-Serag, Rohit Loomba. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and preventionNature Reviews Gastroenterology & Hepatology 2021; 18(4): 223 doi: 10.1038/s41575-020-00381-6
89
Stefania Brozzetti, Chiara D’Alterio, Simone Bini, Jessica Antimi, Bianca Rocco, Alessia Fassari, Pierleone Lucatelli, Piergiorgio Nardis, Michele Di Martino, Giuseppe Maria De Sanctis, Mario Corona, Oreste Bagni, Enrico Cortesi, Mario Bezzi, Carlo Catalano. Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients—A Retrospective Observational StudyCancers 2022; 14(18): 4422 doi: 10.3390/cancers14184422
90
Mikael Sawatzki, Daniela B. Husarik, David Semela. Assessment of focal liver lesions in non-cirrhotic liver – expert opinion statement by the Swiss Association for the Study of the Liver and the Swiss Society of GastroenterologySwiss Medical Weekly 2023; 153(9): 40099 doi: 10.57187/smw.2023.40099
91
Misako Nagasaka, Bayan Al-Share, Yusra F. Shao, Rachel Sexton, Mohammed Najeeb Al Hallak, Asfar S. Azmi, Ammar Sukari. Comprehensive Gut Microbiota2022; : 339 doi: 10.1016/B978-0-12-819265-8.00047-4
92
Siyu Fu, José D. Debes, André Boonstra. DNA methylation markers in the detection of hepatocellular carcinomaEuropean Journal of Cancer 2023; 191: 112960 doi: 10.1016/j.ejca.2023.112960
93
Stefania Brozzetti, Marsia Tancredi, Simone Bini, Chiara De Lucia, Jessica Antimi, Chiara D’Alterio, Giuseppe Maria De Sanctis, Caterina Furlan, Vittoria Carolina Malpassuti, Pierleone Lucatelli, Michele Di Martino, Mario Bezzi, Antonio Ciardi, Rosa Maria Pascale. HCC in the Era of Direct-Acting Antiviral Agents (DAAs): Surgical and Other Curative or Palliative Strategies in the ElderlyCancers 2021; 13(12): 3025 doi: 10.3390/cancers13123025
94
Fabio Sandomenico, Valerio Arpaia, Ferdinando De Rosa, Orlando Catalano, Roberto Antonino Buonaiuto, Marianna Notarangelo, Maria Iovino, Sabrina Giovine, Arturo Brunetti, Mariano Scaglione. Spontaneously Ruptured Hepatocellular Carcinoma: Computed Tomography-Based AssessmentDiagnostics 2023; 13(6): 1021 doi: 10.3390/diagnostics13061021
95
Mahmoud Aryan, Thomas Ruli, Mohamed Shoreibah. HCC in patients without cirrhosis: A reviewClinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000224
96
Ahdab S Bawashkhah, Ghufran A Sindi, Shahad B Almatrafi, Elaf F Obaid, Reda I Bakhsh. Fibrolamellar Hepatocellular Carcinoma in the Absence of Risk Factors: A Case ReportCureus 2022;  doi: 10.7759/cureus.32483
97
Gitanjali Bajaj, Karthik Sundaram, Kedar Jambhekar, Roopa Ram. Imaging After Locoregional Therapy for Hepatocellular Carcinoma With Emphasis on LIRADS Treatment Response Assessment CriteriaSeminars in Ultrasound, CT and MRI 2021; 42(4): 390 doi: 10.1053/j.sult.2021.03.002
98
Sayed Metwaly, Alicja Psica, Opeyemi Sogaolu, Irfan Ahmed, Ashis Mukhopadhya, Mirela Delibegović, Mohamed Bekheit. Volatile organic compounds for the detection of hepatocellular carcinoma—A scoping reviewiLIVER 2024; 3(1): 100070 doi: 10.1016/j.iliver.2023.09.001
99
Bisha Ding, Weiyang Lou, Jingxing Liu, Ruohan Li, Jing Chen, Weimin Fan. In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCCCancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0901-3
100
Monica Pibiri, Gabriella Simbula. Role of the Hippo pathway in liver regeneration and repair: recent advancesInflammation and Regeneration 2022; 42(1) doi: 10.1186/s41232-022-00235-5
101
Yi-Te Lee, Benjamin V. Tran, Jasmine J. Wang, Icy Y. Liang, Sungyong You, Yazhen Zhu, Vatche G. Agopian, Hsian-Rong Tseng, Ju Dong Yang. The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular CarcinomaCancers 2021; 13(12): 3076 doi: 10.3390/cancers13123076
102
Coskun Ozer Demirtas, Maurizia Rossana Brunetto. Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?World Journal of Gastroenterology 2021; 27(33): 5536-5554 doi: 10.3748/wjg.v27.i33.5536
103
Elizabeth SL Low, Ross Apostolov, Darren Wong, Sandra Lin, Numan Kutaiba, Josephine A Grace, Marie Sinclair. Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patientsWorld Journal of Gastrointestinal Oncology 2021; 13(12): 2149-2160 doi: 10.4251/wjgo.v13.i12.2149
104
Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore, Juan C. Camacho. Interventional Management of Portal Hypertension in Cancer PatientsCurrent Oncology Reports 2022; 24(11): 1461 doi: 10.1007/s11912-022-01319-8
105
Georgi Atanasov, Karoline Dino, Katrin Schierle, Corinna Dietel, Gabriela Aust, Johann Pratschke, Daniel Seehofer, Moritz Schmelzle, Hans-Michael Hau. Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosisWorld Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1756-8
106
Valentina Liakina, Sandra Strainiene, Ieva Stundiene, Vaidota Maksimaityte, Edita Kazenaite. Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitisWorld Journal of Hepatology 2022; 14(7): 1277-1290 doi: 10.4254/wjh.v14.i7.1277
107
McKenzie J. White, Eric H. Jensen, David G. Brauer. A Review of Resection and Surgical Ablation for Primary and Secondary Liver CancersSeminars in Interventional Radiology 2023; 40(06): 536 doi: 10.1055/s-0043-1777747
108
A. Riojas-Garza, M. González-Urquijo, C.E. Escareño-Pérez, I. Vázquez-Ávila, F.J. Bosques-Padilla. Carcinoma hepatocelular de lóbulo caudado en un paciente no cirrótico con historia de administración de fenitoína crónica y enfermedad celíaca tratada con resección aislada de lóbulo caudado. Un reporte de casoRevista de Gastroenterología de México 2022; 87(2): 256 doi: 10.1016/j.rgmx.2022.03.001
109
Monika Péčová, Jakub Benko, Martin Jozef Péč, Jakub Jurica, Simona Horná, Tomáš Bolek, Tatiana Hurtová, Ján Sýkora, Kamil Zeleňák, Matej Samoš, Juraj Sokol. A Rare Early-Onset Fatal Complication after Transarterial Chemoembolization: A Case Report and Review of the LiteratureCurrent Oncology 2024; 31(4): 1961 doi: 10.3390/curroncol31040147
110
Moris Sangineto, Rosanna Villani, Francesco Cavallone, Antonino Romano, Domenico Loizzi, Gaetano Serviddio. Lipid Metabolism in Development and Progression of Hepatocellular CarcinomaCancers 2020; 12(6): 1419 doi: 10.3390/cancers12061419
111
Nur Fatin Najihah Marzuki, Yusmazura Zakaria. Medicinal Plants in the Regulation of PD-L1/PD-1 Immune Checkpoint of Various Human Cancer Cells: A Narrative ReviewCurrent Cancer Therapy Reviews 2023; 19(2): 117 doi: 10.2174/1573394718666220829125338
112
Paolo Gallo, Marianna Silletta, Federica Lo Prinzi, Tommaso Farolfi, Alessandro Coppola. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient DiseaseJournal of Clinical Medicine 2023; 12(14): 4605 doi: 10.3390/jcm12144605
113
Rong Liu, Ming-Ping Qian, Ying-Yu Cui. Protein kinases: The key contributors in pathogenesis and treatment of nonalcoholic fatty liver disease-derived hepatocellular carcinomaMetabolism 2023; 147: 155665 doi: 10.1016/j.metabol.2023.155665
114
Edgar Xchel Franco-Juárez, Vianey González-Villasana, María Elena Camacho-Moll, Luisa Rendón-Garlant, Patricia Nefertari Ramírez-Flores, Beatriz Silva-Ramírez, Katia Peñuelas-Urquides, Ethel Daniela Cabello-Ruiz, Fabiola Castorena-Torres, Mario Bermúdez de León. Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2024; 25(3): 1760 doi: 10.3390/ijms25031760
115
Song-Chen Dong, Dou-Sheng Bai, Fu-An Wang, Sheng-Jie Jin, Chi Zhang, Bao-Huan Zhou, Guo-Qing Jiang. Radiofrequency ablation is an inferior option to liver resection for solitary hepatocellular carcinoma ≤ 5 cm without cirrhosis: A population-based study with stratification by tumor sizeHepatobiliary & Pancreatic Diseases International 2023; 22(6): 605 doi: 10.1016/j.hbpd.2022.08.001
116
Anna Michelotti, Marco de Scordilli, Lorenza Palmero, Michela Guardascione, Mario Masala, Rossana Roncato, Luisa Foltran, Elena Ongaro, Fabio Puglisi. NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic SyndromeCells 2021; 10(8): 2034 doi: 10.3390/cells10082034
117
Aditya Kale. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach2022;  doi: 10.5772/intechopen.99839
118
Emilio De Raffele. Liver Diseases2020; : 341 doi: 10.1007/978-3-030-24432-3_31
119
Shohei Kurokawa, Toshiyuki Tanaka, Hiroki Yamazaki, Shunsuke Noguchi, Yusuke Wada, Hidetaka Nishida, Hideo Akiyoshi. Comparing the CT and MRI findings for canine primary hepatocellular lesionsVeterinary Record 2022; 190(11) doi: 10.1002/vetr.1083
120
Runmin Cao, Honghe Jiang, Guangpeng Liang, Weibin Zhang. SEER-based risk stratification system for patients with primary non-cirrhotic liver cancerJournal of Cancer Research and Clinical Oncology 2023; 149(13): 12033 doi: 10.1007/s00432-023-05057-7
121
Kanokwan Pinyopornpanish, Wael Al-Yaman, Srinivasan Dasarathy, Carlos Romero-Marrero, Arthur McCullough. Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and SurvivalDigestive Diseases and Sciences 2022; 67(6): 2677 doi: 10.1007/s10620-021-07048-5
122
Bjarki Sigurdsson, Ragna Sigurdardottir, Margret B. Arnardottir, Sigrun H. Lund, Jon G. Jonasson, Einar S. Björnsson. A nationwide study on hepatocellular carcinomaCancer Epidemiology 2020; 69: 101835 doi: 10.1016/j.canep.2020.101835
123
Poonamjeet Loyal, Samuel Gitau, Soraiya Manji, Sitna Mwanzi, John Weru. Unusual presentation of hepatocellular carcinoma: Case report and review of literatureBJR|case reports 2021; 7(4): 20210033 doi: 10.1259/bjrcr.20210033
124
Emma A. Schindler, Melissa A. Gilbert, David A. Piccoli, Nancy B. Spinner, Ian D. Krantz, Kathleen M. Loomes. Alagille syndrome and risk for hepatocellular carcinoma: Need for increased surveillance in adults with mild liver phenotypesAmerican Journal of Medical Genetics Part A 2021; 185(3): 719 doi: 10.1002/ajmg.a.62028
125
Matthew Thomas, Manjiri Dighe, Orpheus Kolokythas, Mladen Zecevic, Ann Wilson, Todd Erpelding, Theodore J. Dubinsky. Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and Liver Function for Assessing Degree of Steatosis in NAFLD and Non-NAFLD PatientsUltrasound Quarterly 2023; 39(4): 188 doi: 10.1097/RUQ.0000000000000648
126
Nicola Pugliese, Ludovico Alfarone, Ivan Arcari, Silvia Giugliano, Tommaso Lorenzo Parigi, Maria Rescigno, Ana Lleo, Alessio Aghemo. Clinical features and management issues of NAFLD-related HCC: what we know so farExpert Review of Gastroenterology & Hepatology 2023; 17(1): 31 doi: 10.1080/17474124.2023.2162503
127
Nikita Sehgal, Ruchi Jakhmola Mani, Nitu Dogra, Deepshikha Pande Katare. Biosensor Based Advanced Cancer Diagnostics2022; : 97 doi: 10.1016/B978-0-12-823424-2.00009-0
128
Reshmi Mathew, Gregory Churchill, Bakht Cheema, Ketav Desai, Ahmad Alkhasawneh, Shiguang Liu, Anwer Siddiqi. Concomitant Gastric Malignancy and Hepatocellular CarcinomaCureus 2022;  doi: 10.7759/cureus.25607
129
Eloy Ruiz, Pascal Pineau, Claudio Flores, Ramiro Fernández, Luis Cano, Juan Pablo Cerapio, Sandro Casavilca-Zambrano, Francisco Berrospi, Ivan Chávez, Benjamin Roche, Stéphane Bertani. A preoperative nomogram for predicting long-term survival after resection of large hepatocellular carcinoma (>10 cm)HPB 2022; 24(2): 192 doi: 10.1016/j.hpb.2021.06.006
130
Ben L. Da, Aiwu Ruth He, Kirti Shetty, Kelly I. Suchman, Herbert Yu, Lawrence Lau, Linda L. Wong, Atoosa Rabiee, Richard L. Amdur, James M. Crawford, Sharon S. Fox, Gregory M. Grimaldi, Priya K. Shah, Jonathan Weinstein, David Bernstein, Sanjaya K. Satapathy, Nyasha Chambwe, Xiyan Xiang, Lopa Mishra. Pathogenesis to management of hepatocellular carcinomaGenes & Cancer 2022; 13: 72 doi: 10.18632/genesandcancer.226
131
Jonathan H. Joachim, Kosha J. Mehta. Hepcidin in hepatocellular carcinomaBritish Journal of Cancer 2022; 127(2): 185 doi: 10.1038/s41416-022-01753-2
132
Yucel Aydin, Ali R. Koksal, Paul Thevenot, Kelley Nunez, Mohamed Elgamal, Ulkuhan I. Koksal, Tyler Sandow, Martin Moehlen, Frederic Regenstein, Veysel Tahan, Ari Cohen. The number of hepatocellular carcinoma foci as predictor of poor response to tumor-directed therapies in patients awaiting liver transplantation: a prospective cohort studyEuropean Journal of Gastroenterology & Hepatology 2023; 35(10): 1224 doi: 10.1097/MEG.0000000000002631
133
Qian Huang, Xin Xin, QinMei Sun, Ziming An, Xiaojun Gou, Qin Feng. Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLDFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.896899
134
Pranathi Pappu, Urvashi Vijay, Dhatri Madduru, Ngalah Bidii Stephen, Prashanth Suravajhala, Obul Reddy Bandapalli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 22022; : 281 doi: 10.1016/B978-0-323-98807-0.00005-3
135
Nazeer Ahmad Khan, Faisal Rashid, Muhammad Siraj Khan Jadoon, Saquib Jalil, Zulfiqar Ali Khan, Raha Orfali, Shagufta Perveen, Areej Al-Taweel, Jamshed Iqbal, Sohail Anjum Shahzad. Design, Synthesis, and Biological Evaluation of Novel Dihydropyridine and Pyridine Analogs as Potent Human Tissue Nonspecific Alkaline Phosphatase Inhibitors with Anticancer Activity: ROS and DNA Damage-Induced ApoptosisMolecules 2022; 27(19): 6235 doi: 10.3390/molecules27196235
136
Matthew August Odenwald, Sonali Paul. Viral hepatitis: Past, present, and futureWorld Journal of Gastroenterology 2022; 28(14): 1405-1429 doi: 10.3748/wjg.v28.i14.1405
137
Ifrah Fatima, Neehar D. Parikh, Alisa Likhitsup. Controversies of Direct-Acting Antivirals in Hepatocellular CarcinomaSurgical Oncology Clinics of North America 2024; 33(1): 43 doi: 10.1016/j.soc.2023.06.007
138
Mingyan Dong, Qi Cui, Yunong Li, Yujing Li, Qiuyu Chang, Ruixue Bai, Minjiie Wei, Lin zhao, Qili Chen. Ursolic acid suppresses fatty liver-associated hepatocellular carcinoma by regulating lipid metabolismFood Bioscience 2024; 60: 104460 doi: 10.1016/j.fbio.2024.104460
139
Chutian Wu, Yun Zhou, Min Wang, Guolin Dai, Xiongxiu Liu, Leizhen Lai, Shaohui Tang. Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver DiseaseFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.772487
140
Benoit Schmauch, Sarah S. Elsoukkary, Amika Moro, Roma Raj, Chase J. Wehrle, Kazunari Sasaki, Julien Calderaro, Patrick Sin-Chan, Federico Aucejo, Daniel E. Roberts. Combining a deep learning model with clinical data better predicts hepatocellular carcinoma behavior following surgeryJournal of Pathology Informatics 2023; : 100360 doi: 10.1016/j.jpi.2023.100360
141
Zurabi Lominadze, Mohammed Rifat Shaik, Dabin Choi, Duha Zaffar, Lopa Mishra, Kirti Shetty. Hepatocellular Carcinoma Genetic ClassificationThe Cancer Journal 2023; 29(5): 249 doi: 10.1097/PPO.0000000000000682
142
Sanaz Pashapour, Masoumeh Heshmati, Zahra Mousavi, Somayeh Esmaeili. The Cytotoxicity of the Chloroform and Petroleum Ether Fractional Extracts of Galium verum L. in HepG2 and HT29 Cell LinesJournal of Kermanshah University of Medical Sciences 2020; 24(2) doi: 10.5812/jkums.101079
143
Neha Merchant, Sujatha Peela, Afroz Alam, Ganji Purnachandra Nagaraju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 32022; : 161 doi: 10.1016/B978-0-323-99283-1.00025-2
144
Sachin Sharma, Shaikh Maryam Ghufran, Basundhara Das, Bornika Roy, Sampa Ghose, Subhrajit Biswas. Survivin expression is essential for early activation of hepatic stellate cells and fibrosis progression in chronic liver injuryLife Sciences 2021; 287: 120119 doi: 10.1016/j.lfs.2021.120119
145
Matthias Van Haele, Janne Snoeck, Tania Roskams. Human Liver Regeneration: An Etiology Dependent ProcessInternational Journal of Molecular Sciences 2019; 20(9): 2332 doi: 10.3390/ijms20092332
146
Pablo Lozano Lominchar, Maitane Igone Orue-Echebarria, Lorena Martín, Cristina Julia Lisbona, María Magdalena Salcedo, Luis Olmedilla, Hemant Sharma, Jose Manuel Asencio, José Ángel López-Baena. Hepatic flow is an intraoperative predictor of early allograft dysfunction in whole-graft deceased donor liver transplantation: An observational cohort studyWorld Journal of Hepatology 2019; 11(9): 689-700 doi: 10.4254/wjh.v11.i9.689
147
Shih-Wei Yang, Wei-Liang Chen, Wei-Te Wu, Chung-Ching Wang. Investigation on returning to work in liver cancer survivors in Taiwan: a 5-year follow-up studyBMC Public Health 2021; 21(1) doi: 10.1186/s12889-021-11872-9
148
Cemil Colak, Zeynep Kucukakcali, Sami Akbulut. Artificial intelligence-based prediction of molecular and genetic markers for hepatitis C–related hepatocellular carcinomaAnnals of Medicine & Surgery 2023; 85(10): 4674 doi: 10.1097/MS9.0000000000001210
149
Sonia Pascual, Cayetano Miralles, Juan M Bernabé, Javier Irurzun, Mariana Planells. Surveillance and diagnosis of hepatocellular carcinoma: A systematic reviewWorld Journal of Clinical Cases 2019; 7(16): 2269-2286 doi: 10.12998/wjcc.v7.i16.2269
150
Magdalena Stepien, Pekka Keski‐Rahkonen, Agneta Kiss, Nivonirina Robinot, Talita Duarte‐Salles, Neil Murphy, Gabriel Perlemuter, Vivian Viallon, Anne Tjønneland, Agnetha Linn Rostgaard‐Hansen, Christina C. Dahm, Kim Overvad, Marie‐Christine Boutron‐Ruault, Francesca Romana Mancini, Yahya Mahamat‐Saleh, Krasimira Aleksandrova, Rudolf Kaaks, Tilman Kühn, Antonia Trichopoulou, Anna Karakatsani, Salvatore Panico, Rosario Tumino, Domenico Palli, Giovanna Tagliabue, Alessio Naccarati, Roel C.H. Vermeulen, Hendrik Bastiaan Bueno‐de‐Mesquita, Elisabete Weiderpass, Guri Skeie, Jose Ramón Quirós, Eva Ardanaz, Olatz Mokoroa, Núria Sala, Maria‐Jose Sánchez, José María Huerta, Anna Winkvist, Sophia Harlid, Bodil Ohlsson, Klas Sjöberg, Julie A. Schmidt, Nick Wareham, Kay‐Tee Khaw, Pietro Ferrari, Joseph A. Rothwell, Marc Gunter, Elio Riboli, Augustin Scalbert, Mazda Jenab. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort studyInternational Journal of Cancer 2021; 148(3): 609 doi: 10.1002/ijc.33236
151
Lateef A. Sulaimon, Rahmat A. Adisa, Titilola A. Samuel, Fatimah B. Abdulkareem, Akinrinade G. Ayankojo. Mitoquinol mesylate alleviates oxidative damage in cirrhotic and advanced hepatocellular carcinogenic rats through mitochondrial protection and antioxidative effectsAdvances in Redox Research 2021; 3: 100014 doi: 10.1016/j.arres.2021.100014
152
Haeryoung Kim, Wei-Qiang Leow, Regina Lo, Paulo Giovanni L. Mendoza, Anthony Wing-Hung Chan. Atlas of Hepatocellular Carcinoma Pathology2022; : 1 doi: 10.1007/978-981-16-8500-2_1
153
Luis Cesar Bredt, Ingryd Betina Garcia Felisberto, Doroty Eva Garcia Felisberto. Is there a role for liver transplantation in the treatment of hepatocellular carcinoma in non-cirrhotic liver?World Journal of Meta-Analysis 2022; 10(2): 46-51 doi: 10.13105/wjma.v10.i2.46
154
Said A. Al-Busafi, Khalid AlNaamani. Liver Cancer in the Middle East2021; : 259 doi: 10.1007/978-3-030-78737-0_17
155
Catherine Leyh, Jason D. Coombes, Hartmut H. Schmidt, Ali Canbay, Paul P. Manka, Jan Best. MASLD-Related HCC—Update on Pathogenesis and Current Treatment OptionsJournal of Personalized Medicine 2024; 14(4): 370 doi: 10.3390/jpm14040370
156
Gehad Ahmad Saleh, Ahmed Abdel Khalek Abdel Razek, Lamiaa Galal El-Serougy, Walaa Shabana, Rihame Abd El-Wahab. The value of the apparent diffusion coefficient value in the Liver Imaging Reporting and Data System version 2018Polish Journal of Radiology 2022; 87: 43 doi: 10.5114/pjr.2022.113193
157
Manfred Schmidt, Graham R. Foster, Michiel Coppens, Hauke Thomsen, Ricardo Dolmetsch, Liesbeth Heijink, Paul E. Monahan, Steven W. Pipe. Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia BBlood Advances 2023; 7(17): 4966 doi: 10.1182/bloodadvances.2023009876
158
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]2019;  doi: 10.5772/intechopen.86638
159
Na Young Lee, Ki Tae Suk. The Role of the Gut Microbiome in Liver Cirrhosis TreatmentInternational Journal of Molecular Sciences 2020; 22(1): 199 doi: 10.3390/ijms22010199
160
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, Ragesh B Thandassery, Emmanouil Giorgakis. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancementsWorld Journal of Gastroenterology 2021; 27(24): 3466-3482 doi: 10.3748/wjg.v27.i24.3466
161
Shintaro Ichikawa, Hiroyuki Morisaka, Yoshie Omiya, Hiroshi Onishi. Distinction Between Hepatocellular Carcinoma and Hypervascular Liver Metastases in Non-cirrhotic Patients Using Gadoxetate Disodium-Enhanced Magnetic Resonance ImagingCanadian Association of Radiologists Journal 2022; 73(4): 639 doi: 10.1177/08465371221085516
162
Sonia Triggiani, Maria T. Contaldo, Giulia Mastellone, Maurizio Cè, Anna M. Ierardi, Gianpaolo Carrafiello, Michaela Cellina. The Role of Artificial Intelligence and Texture Analysis in Interventional Radiological Treatments of Liver Masses: A Narrative Review Critical Reviews™ in Oncogenesis 2024; 29(2): 37 doi: 10.1615/CritRevOncog.2023049855
163
Joo Hyun Oh, Myung Ji Goh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik. Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related EventsDigestive Diseases and Sciences 2021; 66(8): 2816 doi: 10.1007/s10620-020-06591-x
164
Naima Zayed Mohamed, Hanan Farouk Aly, Hatem Abdel moneim El-Mezayen, Hadeer E. El-Salamony. Effect of co-administration of Bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in ratsToxicology Reports 2019; 6: 875 doi: 10.1016/j.toxrep.2019.08.007
165
Susanne Feder, Arne Kandulski, Doris Schacherer, Thomas S. Weiss, Christa Buechler. Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2019; 20(16): 3919 doi: 10.3390/ijms20163919
166
Robert M. Shavelle, Ji Hun Kwak, Rachel Saur, Jordan C. Brooks, Philip Rosenthal. Life Expectancy after Liver Transplantation for Non-Cirrhotic Hepatocellular CarcinomaProgress in Transplantation 2021; 31(2): 117 doi: 10.1177/15269248211002793
167
Siyu Fu, Teoman Deger, Ruben G. Boers, Joachim B. Boers, Michael Doukas, Joost Gribnau, Saskia M. Wilting, José D. Debes, Andre Boonstra. Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular CarcinomaCancers 2023; 15(19): 4784 doi: 10.3390/cancers15194784
168
Yaojie Fu, Luca Maccioni, Xin Wei Wang, Tim F. Greten, Bin Gao. Alcohol-associated liver cancerHepatology 2024;  doi: 10.1097/HEP.0000000000000890
169
Gianni TESTINO, Sharmila FAGOONEE, Fabio CAPUTO, Rinaldo PELLICANO. The early identification of alcohol use disorders and liver injury: proposal for a diagnostic algorithmPanminerva Medica 2021; 63(3) doi: 10.23736/S0031-0808.21.04272-5
170
Cristiane Valle Tovo, Angelo Zambam de Mattos, Gabriela Perdomo Coral, Giovana D P Sartori, Livia Villela Nogueira, Gustavo Tovo Both, Cristiane A Villela-Nogueira, Angelo A de Mattos. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosisWorld Journal of Gastroenterology 2023; 29(2): 343-356 doi: 10.3748/wjg.v29.i2.343
171
Juliet Emamaullee, Ali N. Zaidi, Thomas Schiano, Jeffrey Kahn, Pamela L. Valentino, Ryan E. Hofer, Timucin Taner, Joyce W. Wald, Kim M. Olthoff, John Bucuvalas, Ryan Fischer. Fontan-Associated Liver DiseaseCirculation 2020; 142(6): 591 doi: 10.1161/CIRCULATIONAHA.120.045597
172
Davide Giuseppe Ribaldone, Gian Paolo Caviglia, Silvia Gaia, Emanuela Rolle, Alessandra Risso, Daniela Campion, Paola Rita Brunocilla, Giorgio Maria Saracco, Patrizia Carucci. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West ItalyCurrent Oncology 2022; 29(3): 1422 doi: 10.3390/curroncol29030119
173
A. Riojas-Garza, M. González-Urquijo, C.E. Escareño-Pérez, I. Vázquez-Ávila, F.J. Bosques-Padilla. Caudate lobe hepatocellular carcinoma in a noncirrhotic patient with a history of chronic phenytoin intake and celiac disease treated with isolated caudate lobe resection. A case reportRevista de Gastroenterología de México (English Edition) 2022; 87(2): 256 doi: 10.1016/j.rgmxen.2022.05.011
174
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation2021; : 89 doi: 10.1016/B978-0-7020-7584-1.00006-1
175
Abid M. Sadiq, Tendai J. Mashonganyika, Lilian G. Mmbaga, Adnan M. Sadiq, Gilbert Z. Nkya. Hepatocellular carcinoma in a non‐cirrhotic liver with a tumor thrombusClinical Case Reports 2021; 9(9) doi: 10.1002/ccr3.4800
176
Sancharan Acharya, Subramaniyam Nithyananthan, Chinnasamy Thirunavukkarasu. Selenium Nanoparticles Show Anticancer Activity Through Regulation of HIF-1α and HIF-2α Under Hypoxic Condition in Liver Cancer CellsDNA and Cell Biology 2023; 42(7): 433 doi: 10.1089/dna.2023.0099
177
Akiko Eguchi, Motoh Iwasa, Minori Yamada, Yasuyuki Tamai, Ryuta Shigefuku, Hiroshi Hasegawa, Yoshifumi Hirokawa, Akinobu Hayashi, Koji Okuno, Yuki Matsushita, Takuma Nakatsuka, Kenichiro Enooku, Koji Sakaguchi, Yoshinao Kobayashi, Tetsuji Yamaguchi, Masatoshi Watanabe, Yoshiyuki Takei, Hayato Nakagawa. A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitisHepatology Communications 2022; 6(8): 1987 doi: 10.1002/hep4.1971
178
Adrià Ramírez Mena, Mbaye Thiam, Daye Ka, Ibrahima Niang, Judicaël Tine, Louise Fortes, Kiné Ndiaye, Ousseynou Ndiaye, Maguette Fall, Assietou Gaye, Ndeye Fatou Ngom, Fatou Fall, Annalisa Berzigotti, Gregory Dale Kirk, Antoine Jaquet, Moussa Seydi, Gilles Wandeler. Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort studyThe Lancet Gastroenterology & Hepatology 2024; 9(6): 539 doi: 10.1016/S2468-1253(24)00040-2
179
Kazuma Sekiba, Motoyuki Otsuka, Kazuhiko Koike. Potential of HBx Gene for Hepatocarcinogenesis in Noncirrhotic LiverSeminars in Liver Disease 2021; 41(02): 142 doi: 10.1055/s-0041-1723033
180
Zhenghong Lee, Zheng-Rong Lu, Sandra Sexton, Wei Xin. PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging 2023; 50(11): 3190 doi: 10.1007/s00259-023-06324-y
181
Yu-Jen Chen, Chien-Wei Su, Cheng-Yi Wei, Gar-Yang Chau, Ping-Hsien Chen, Yee Chao, Yi-Hsiang Huang, Jaw-Ching Wu, Tsung-Chieh Yang, Pei-Chang Lee, Ming-Chih Hou. Comparison of prognoses between cirrhotic and noncirrhotic patients with hepatocellular carcinoma and esophageal varices undergoing surgical resectionJournal of the Chinese Medical Association 2022; 85(6): 679 doi: 10.1097/JCMA.0000000000000739
182
Priya Singh, Parul Gupta, Arka De, Ajay Duseja. Molecular Characterization of Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis: Implications for ImmunotherapyJournal of Clinical and Experimental Hepatology 2023; 13(6): 1140 doi: 10.1016/j.jceh.2023.03.001
183
Ruzan Udumyan, Scott Montgomery, Ann-Sofi Duberg, Fang Fang, Unnur Valdimarsdottir, Anders Ekbom, Karin E. Smedby, Katja Fall. Beta-adrenergic receptor blockers and liver cancer mortality in a national cohort of hepatocellular carcinoma patientsScandinavian Journal of Gastroenterology 2020; 55(5): 597 doi: 10.1080/00365521.2020.1762919
184
Norberto C Chavez-Tapia, Sofía Murúa-Beltrán Gall, Ana Luisa Ordoñez-Vázquez, Natalia Nuño-Lambarri, Paulina Vidal-Cevallos, Misael Uribe. Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2022; : 583 doi: 10.2147/JHC.S283840
185
Souvik Sarkar, Aniket Alurwar, Carole Ly, Cindy Piao, Rajiv Donde, Christopher J. Wang, Frederick J. Meyers. A Machine Learning Model to Predict Risk for Hepatocellular Carcinoma in Patients With Metabolic Dysfunction-Associated Steatotic Liver DiseaseGastro Hep Advances 2024; 3(4): 498 doi: 10.1016/j.gastha.2024.01.007
186
Jong Man Kim, Jinsoo Rhu, Sang Yun Ha, Gyu-Seong Choi, Choon Hyuck David Kwon, Jae-Won Joh. Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosisAnnals of Surgical Treatment and Research 2022; 102(1): 1 doi: 10.4174/astr.2022.102.1.1
187
Sangmi Jang, Young-Joo Jin, Jin-Woo Lee, Dam Kwon, Jung Hwan Yu. Risk factors associated with late hepatocellular carcinoma detection in patients undergoing regular surveillanceMedicine 2023; 102(32): e34637 doi: 10.1097/MD.0000000000034637
188
Martijn P.A. Starmans, Razvan L. Miclea, Valerie Vilgrain, Maxime Ronot, Yvonne Purcell, Jef Verbeek, Wiro J. Niessen, Jan N.M. Ijzermans, Rob A. de Man, Michael Doukas, Stefan Klein, Maarten G. Thomeer. Automated Assessment of T2-Weighted MRI to Differentiate Malignant and Benign Primary Solid Liver Lesions in Noncirrhotic Livers Using RadiomicsAcademic Radiology 2024; 31(3): 870 doi: 10.1016/j.acra.2023.07.024
189
Brian McMahon, Chari Cohen, Robert S Brown Jr, Hashem El-Serag, George N Ioannou, Anna S Lok, Lewis R Roberts, Amit G Singal, Timothy Block. Opportunities to address gaps in early detection and improve outcomes of liver cancerJNCI Cancer Spectrum 2023; 7(3) doi: 10.1093/jncics/pkad034
190
Anisha Jain, Benjamin Mazer, Yanhong Deng, Maria Ciarleglio, Dhanpat Jain, Tamar Taddei, Xuchen Zhang. Hepatocellular CarcinomaAmerican Journal of Clinical Pathology 2022; 157(2): 305 doi: 10.1093/ajcp/aqab125
191
L.E. Cisneros-Garza, M.S. González-Huezo, C. Moctezuma-Velázquez, L. Ladrón de Guevara-Cetina, M. Vilatobá, I. García-Juárez, R. Alvarado-Reyes, G.A. Álvarez-Treviño, S. Allende-Pérez, L. Bornstein-Quevedo, G. Calderillo-Ruiz, M.A. Carrillo-Martínez, M. Castillo-Barradas, E. Cerda-Reyes, J.A. Félix-Leyva, J.A. Gabutti-Thomas, J. Guerrero-Ixtlahuac, F. Higuera-de-la-Tijera, D. Huitzil-Meléndez, E. Kimura-Hayama, P.A. López-Hernández, R. Malé-Velázquez, N. Méndez-Sánchez, M.A. Morales-Ruiz, E. Ruíz-García, J.F. Sánchez-Ávila, L. Torrecillas-Torres. II Consenso Mexicano de Carcinoma Hepatocelular. Parte I: Epidemiología y diagnósticoRevista de Gastroenterología de México 2022; 87(2): 216 doi: 10.1016/j.rgmx.2021.10.002
192
Alisa A. Petkevich, Aleksandr A. Abramov, Vadim I. Pospelov, Natalya A. Malinina, Elena I. Kuhareva, Natalya V. Mazurchik, Olga I. Tarasova. Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancerOncotarget 2021; 12(17): 1697 doi: 10.18632/oncotarget.28036
193
Saleh A. Alqahtani, Wah-Kheong Chan, Ming-Lung Yu. Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular CarcinomaClinics in Liver Disease 2023; 27(2): 211 doi: 10.1016/j.cld.2023.01.019
194
Sofi Dhanaraj, Tahir Shah, Joanne O'Rourke, Shishir Shetty. Hepatocellular carcinoma: update on treatment guidelinesGastrointestinal Nursing 2020; 18(Sup10): S18 doi: 10.12968/gasn.2020.18.Sup10.S18